MARKET WIRE NEWS

Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-07 06:30:31 ET

Compugen Ltd. (CGEN)

Q2 2025 Earnings Conference Call

August 06, 2025, 08:30 AM ET

Company Participants

Anat Cohen-Dayag - CEO, President & Director

David Silberman - Chief Financial Officer

Eran Ophir - Chief Scientific Officer

Michelle Mahler - Chief Medical Officer

Yvonne Naughton - Head of Investor Relations & Corporate Communications

Conference Call Participants

Leland James Gershell - Oppenheimer & Co. Inc., Research Division

Presentation

Operator

Ladies and gentlemen, thank you for joining us today. Welcome to the Compugen Ltd. Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] An audio webcast of this call is available in the Investors section of Compugen's website, www.cgen.com. As a reminder, today's call is being recorded....

Read the full article on Seeking Alpha

For further details see:

Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript
Compugen Ltd.

NASDAQ: CGEN

CGEN Trading

4.78% G/L:

$2.30 Last:

224,627 Volume:

$2.19 Open:

mwn-alerts Ad 300

CGEN Latest News

CGEN Stock Data

$165,050,413
90,614,080
N/A
90
N/A
Biotechnology & Life Sciences
Healthcare
IL
Holon

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App